Roep Reducing Proinsulin-Specific CD 8 + T Cells in Type 1 Diabetes Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically
暂无分享,去创建一个
W. Hagopian | W. Robinson | H. Garren | L. Steinman | J. Buse | G. Eisenbarth | Liping Yu | L. Harrison | N. Solvason | P. Utz | B. Roep | P. Gottlieb | M. Herrath | J. R. Abreu | M. Leviten | R. King | Joanne Quan
[1] O. Kordonouri,et al. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus , 2013 .
[2] J. Drijfhout,et al. Islet-Specific CTL Cloned from a Type 1 Diabetes Patient Cause Beta-Cell Destruction after Engraftment into HLA-A2 Transgenic NOD/SCID/IL2RG Null Mice , 2012, PloS one.
[3] C. Stokes,et al. Preexisting Autoantibodies Predict Efficacy of Oral Insulin to Cure Autoimmune Diabetes in Combination With Anti-CD3 , 2012, Diabetes.
[4] M. Atkinson,et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients , 2012, The Journal of experimental medicine.
[5] M. V. von Herrath,et al. Humanizing Animal Models: A Key to Autoimmune Diabetes Treatment , 2011, Science Translational Medicine.
[6] Bart O. Roep,et al. Simultaneous Detection of Circulating Autoreactive CD8+ T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers , 2010, Diabetes.
[7] J. Ringers,et al. Accumulation of autoreactive effector T cells and allo-specific regulatory T cells in the pancreas allograft of a type 1 diabetic recipient , 2009, Diabetologia.
[8] H. Garren,et al. Improved Efficacy of a Tolerizing DNA Vaccine for Reversal of Hyperglycemia through Enhancement of Gene Expression and Localization to Intracellular Sites , 2008, The Journal of Immunology.
[9] H. Kolb,et al. Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes , 2008, Diabetes Care.
[10] J. Drijfhout,et al. Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes , 2005 .
[11] D. Hafler,et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope , 2005, Nature.
[12] J. Krischer,et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. , 2005, Diabetes care.
[13] Mark Peakman,et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. , 2004, The Journal of clinical investigation.
[14] P. Fontoura,et al. An Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune Systems 1 , 2003, The Journal of Immunology.
[15] P. Bingley,et al. The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence , 2003, Diabetologia.
[16] M. Knip,et al. Intranasally administered insulin intended for prevention of type 1 diabetes—a safety study in healthy adults , 2003, Diabetes/metabolism research and reviews.
[17] L. Harrison,et al. Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes. , 2003, Diabetes.
[18] M. Rewers,et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. V. von Herrath,et al. DNA immunization to prevent autoimmune diabetes. , 1999, The Journal of clinical investigation.
[20] P. Bingley,et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. , 1998, Diabetes.
[21] H. Chase,et al. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects , 1997, Diabetologia.
[22] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[23] J. Drijfhout,et al. Autoreactive CD 8 T cells associated with cell destruction in type 1 diabetes , 2005 .
[24] G. A. Fleming,et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. , 2004, Diabetes.
[25] Bart O. Roep Dr.. The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure , 2003, Diabetologia.